Collagen vascular diseases and disorders of connective tissue

Kelly J. Butnor, Andras Khoor

Research output: Chapter in Book/Report/Conference proceedingChapter

6 Citations (Scopus)

Abstract

The collagen vascular diseases, also referred to as connective tissue diseases, are a diverse group of systemic inflammatory disorders thought to be immunologically mediated. The concept of collagen vascular disease began to take shape in the 1930s, when it was recognized that rheumatic fever and rheumatoid arthritis can affect connective tissues throughout the body.1,2 During the following decade, as conditions such as systemic lupus erythematosus (SLE) and scleroderma came to be viewed as systemic diseases of connective tissue, the terms diffuse connective disease and diffuse collagen disease were proposed.3,4 During the same period, the designation of diffuse vascular disease was proposed for diseases such as scleroderma, polymyositis, SLE, and polyarteritis nodosa, which featured widespread vascular involvement.5 With the realization that many of these entities can exhibit both systemic connective tissue manifestations and vascular abnormalities, the unifying designation of collagen vascular disease was introduced.6

Original languageEnglish (US)
Title of host publicationDail and Hammar's Pulmonary Pathology
PublisherSpringer New York
Pages722-759
Number of pages38
Volume1
ISBN (Print)9780387983950
DOIs
StatePublished - 2008

Fingerprint

Collagen Diseases
Vascular Diseases
Connective Tissue
Connective Tissue Diseases
Rheumatic Fever
Systemic Lupus Erythematosus
Blood Vessels
Polymyositis
Polyarteritis Nodosa
Rheumatoid Arthritis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Butnor, K. J., & Khoor, A. (2008). Collagen vascular diseases and disorders of connective tissue. In Dail and Hammar's Pulmonary Pathology (Vol. 1, pp. 722-759). Springer New York. https://doi.org/10.1007/978-0-387-68792-6_20

Collagen vascular diseases and disorders of connective tissue. / Butnor, Kelly J.; Khoor, Andras.

Dail and Hammar's Pulmonary Pathology. Vol. 1 Springer New York, 2008. p. 722-759.

Research output: Chapter in Book/Report/Conference proceedingChapter

Butnor, KJ & Khoor, A 2008, Collagen vascular diseases and disorders of connective tissue. in Dail and Hammar's Pulmonary Pathology. vol. 1, Springer New York, pp. 722-759. https://doi.org/10.1007/978-0-387-68792-6_20
Butnor KJ, Khoor A. Collagen vascular diseases and disorders of connective tissue. In Dail and Hammar's Pulmonary Pathology. Vol. 1. Springer New York. 2008. p. 722-759 https://doi.org/10.1007/978-0-387-68792-6_20
Butnor, Kelly J. ; Khoor, Andras. / Collagen vascular diseases and disorders of connective tissue. Dail and Hammar's Pulmonary Pathology. Vol. 1 Springer New York, 2008. pp. 722-759
@inbook{b1fb47c510a74f60a3db03f2d7dead68,
title = "Collagen vascular diseases and disorders of connective tissue",
abstract = "The collagen vascular diseases, also referred to as connective tissue diseases, are a diverse group of systemic inflammatory disorders thought to be immunologically mediated. The concept of collagen vascular disease began to take shape in the 1930s, when it was recognized that rheumatic fever and rheumatoid arthritis can affect connective tissues throughout the body.1,2 During the following decade, as conditions such as systemic lupus erythematosus (SLE) and scleroderma came to be viewed as systemic diseases of connective tissue, the terms diffuse connective disease and diffuse collagen disease were proposed.3,4 During the same period, the designation of diffuse vascular disease was proposed for diseases such as scleroderma, polymyositis, SLE, and polyarteritis nodosa, which featured widespread vascular involvement.5 With the realization that many of these entities can exhibit both systemic connective tissue manifestations and vascular abnormalities, the unifying designation of collagen vascular disease was introduced.6",
author = "Butnor, {Kelly J.} and Andras Khoor",
year = "2008",
doi = "10.1007/978-0-387-68792-6_20",
language = "English (US)",
isbn = "9780387983950",
volume = "1",
pages = "722--759",
booktitle = "Dail and Hammar's Pulmonary Pathology",
publisher = "Springer New York",

}

TY - CHAP

T1 - Collagen vascular diseases and disorders of connective tissue

AU - Butnor, Kelly J.

AU - Khoor, Andras

PY - 2008

Y1 - 2008

N2 - The collagen vascular diseases, also referred to as connective tissue diseases, are a diverse group of systemic inflammatory disorders thought to be immunologically mediated. The concept of collagen vascular disease began to take shape in the 1930s, when it was recognized that rheumatic fever and rheumatoid arthritis can affect connective tissues throughout the body.1,2 During the following decade, as conditions such as systemic lupus erythematosus (SLE) and scleroderma came to be viewed as systemic diseases of connective tissue, the terms diffuse connective disease and diffuse collagen disease were proposed.3,4 During the same period, the designation of diffuse vascular disease was proposed for diseases such as scleroderma, polymyositis, SLE, and polyarteritis nodosa, which featured widespread vascular involvement.5 With the realization that many of these entities can exhibit both systemic connective tissue manifestations and vascular abnormalities, the unifying designation of collagen vascular disease was introduced.6

AB - The collagen vascular diseases, also referred to as connective tissue diseases, are a diverse group of systemic inflammatory disorders thought to be immunologically mediated. The concept of collagen vascular disease began to take shape in the 1930s, when it was recognized that rheumatic fever and rheumatoid arthritis can affect connective tissues throughout the body.1,2 During the following decade, as conditions such as systemic lupus erythematosus (SLE) and scleroderma came to be viewed as systemic diseases of connective tissue, the terms diffuse connective disease and diffuse collagen disease were proposed.3,4 During the same period, the designation of diffuse vascular disease was proposed for diseases such as scleroderma, polymyositis, SLE, and polyarteritis nodosa, which featured widespread vascular involvement.5 With the realization that many of these entities can exhibit both systemic connective tissue manifestations and vascular abnormalities, the unifying designation of collagen vascular disease was introduced.6

UR - http://www.scopus.com/inward/record.url?scp=77956932995&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956932995&partnerID=8YFLogxK

U2 - 10.1007/978-0-387-68792-6_20

DO - 10.1007/978-0-387-68792-6_20

M3 - Chapter

AN - SCOPUS:77956932995

SN - 9780387983950

VL - 1

SP - 722

EP - 759

BT - Dail and Hammar's Pulmonary Pathology

PB - Springer New York

ER -